Financials
- Market Capitalization 652.72 M
- Employee 191
- Founded 2006
- CEO N/A
- Website www.cormedix.com
- Headquarter Delaware, United States
- FIGI BBG000Q4BQK0
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2721 | PTCT PTC Therapeutics, Inc. - Common Stock | 80.81 USD | -4.76% | -6.24% | +8.16% | +66.00% | 670.31 M USD | ||
| 2724 | BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 8.39 USD | +0.84% | -1.06% | +9.39% | -11.59% | 672.10 M USD | ||
| 2744 | ALLO Allogene Therapeutics, Inc. - Common Stock | 1.93 USD | -3.50% | -8.10% | +2.66% | +51.97% | 666.15 M USD | ||
| 2750 | TECX Tectonic Therapeutic, Inc. - Common Stock | 34.46 USD | +0.26% | -3.74% | +17.61% | +100.93% | 650.23 M USD |
Frequently asked questions about CorMedix Inc. - Common Stock
What is the CorMedix Inc. - Common Stock stock price today?
The current price of CorMedix Inc. - Common Stock (CRMD) is 8.32. Over the past 24 hours, the stock has changed by -0.95%. Follow the CRMD chart for real-time price dynamics.
What is the stock ticker of CorMedix Inc. - Common Stock?
CorMedix Inc. - Common Stock trades under the ticker CRMD. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is CorMedix Inc. - Common Stock stock going up?
CRMD has changed by -3.37% over the last week, -7.25% over the last month, and -26.37% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was CorMedix Inc. - Common Stock net income for the last quarter?
CorMedix Inc. - Common Stock reported net income of 38.6 M for the last quarter. The previous quarter showed 14.02 M, which means net income changed by +175.33%.
How many employees does CorMedix Inc. - Common Stock have?
As of the latest available data, CorMedix Inc. - Common Stock has 191 employees. Workforce size can provide additional context about the company's scale and operations.
What is CorMedix Inc. - Common Stock EBITDA?
CorMedix Inc. - Common Stock EBITDA is 84.5 M, and its EBITDA margin is 66.31%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy CorMedix Inc. - Common Stock stock?
You can buy CorMedix Inc. - Common Stock (CRMD) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in CorMedix Inc. - Common Stock stock?
Investing in CorMedix Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CRMD chart and related analysis on metatrader.com as part of your research.